Literature DB >> 24621583

Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease.

Takuya Kitamoto1, Aya Kitamoto1, Masato Yoneda2, Hideyuki Hyogo3, Hidenori Ochi3, Seiho Mizusawa1, Takato Ueno4, Kazuwa Nakao5, Akihiro Sekine1, Kazuaki Chayama3, Atsushi Nakajima2, Kikuko Hotta1.   

Abstract

The genomic regions containing PNPLA3, SAMM50 and PARVB are susceptibility loci for the development and progression of nonalcoholic fatty liver disease (NAFLD). In order to search for all common variations in this region, we amplified the genomic DNA of 28 NAFLD patients by long-range PCR, covering the entire susceptibility region and sequenced the DNA using indexed multiplex next-generation sequencing. We found 329 variations, including four novel variations. Fine mapping of variations including insertion/deletions was performed for 540 NAFLD patients (488 with nonalcoholic steatohepatitis (NASH) and 52 with simple steatosis) and 1012 control subjects. HaploView analysis showed that linkage disequilibrium (LD) block 1 and 2 occurred in PNPLA3, block 3 in SAMM50 and block 4 in PARVB. Variations in LD blocks 1-4 were significantly associated with NAFLD as compared with control subjects (P<1 × 10(-8)). Variations in LD block 2 were significantly associated with the NAFLD activity score (NAS), aspartate aminotransferase and alanine aminotransferase. Variations in LD block 1 were significantly associated with the fibrosis stage. The strongest associations were observed for variations in LD block 4, with NASH as compared with simple steatosis (P=7.1 × 10(-6)) and NAS (P=3.4 × 10(-6)). Our results suggested that variations, including insertion/deletions, in PARVB, as well as those in PNPLA3, are important in the progression of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24621583     DOI: 10.1038/jhg.2014.17

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  38 in total

1.  A high-throughput SNP typing system for genome-wide association studies.

Authors:  Y Ohnishi; T Tanaka; K Ozaki; R Yamada; H Suzuki; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

Review 2.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

Review 3.  Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2011-05-14       Impact factor: 17.425

4.  Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

Authors:  Takuya Kitamoto; Aya Kitamoto; Masato Yoneda; Hideyuki Hyogo; Hidenori Ochi; Takahiro Nakamura; Hajime Teranishi; Seiho Mizusawa; Takato Ueno; Kazuaki Chayama; Atsushi Nakajima; Kazuwa Nakao; Akihiro Sekine; Kikuko Hotta
Journal:  Hum Genet       Date:  2013-03-28       Impact factor: 4.132

Review 5.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

6.  Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.

Authors:  Masato Yoneda; Kikuko Hotta; Yuichi Nozaki; Hiroki Endo; Takashi Uchiyama; Hironori Mawatari; Hiroshi Iida; Shingo Kato; Koji Fujita; Hirokazu Takahashi; Hiroyuki Kirikoshi; Noritoshi Kobayashi; Masahiko Inamori; Yasunobu Abe; Kensuke Kubota; Satoru Saito; Shiro Maeyama; Koichiro Wada; Atsushi Nakajima
Journal:  Liver Int       Date:  2009-03-03       Impact factor: 5.828

7.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

8.  Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.

Authors:  Kikuko Hotta; Masato Yoneda; Hideyuki Hyogo; Hidenori Ochi; Seiho Mizusawa; Takato Ueno; Kazuaki Chayama; Atsushi Nakajima; Kazuwa Nakao; Akhiro Sekine
Journal:  BMC Med Genet       Date:  2010-12-22       Impact factor: 2.103

9.  Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.

Authors:  Takahisa Kawaguchi; Yoshio Sumida; Atsushi Umemura; Keitaro Matsuo; Meiko Takahashi; Toshinari Takamura; Kohichiroh Yasui; Toshiji Saibara; Etsuko Hashimoto; Miwa Kawanaka; Sumio Watanabe; Sumio Kawata; Yasuharu Imai; Miki Kokubo; Toshihide Shima; Hyohun Park; Hideo Tanaka; Kazuo Tajima; Ryo Yamada; Fumihiko Matsuda; Takeshi Okanoue
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

10.  A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.

Authors:  Shamsul Mohd Zain; Rosmawati Mohamed; Sanjiv Mahadeva; Phaik Leng Cheah; Sanjay Rampal; Roma Choudhury Basu; Zahurin Mohamed
Journal:  Hum Genet       Date:  2012-01-19       Impact factor: 4.132

View more
  7 in total

1.  Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma.

Authors:  Suguru Kurokawa; Masato Yoneda; Yuji Ogawa; Yasushi Honda; Takaomi Kessoku; Kento Imajo; Satoru Saito; Atsushi Nakajima; Kikuko Hotta
Journal:  BMC Gastroenterol       Date:  2022-06-02       Impact factor: 2.847

2.  Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.

Authors:  Nobuharu Tamaki; Masayuki Kurosaki; Mayu Higuchi; Hitomi Takada; Natsuko Nakakuki; Yutaka Yasui; Shoko Suzuki; Kaoru Tsuchiya; Hiroyuki Nakanishi; Jun Itakura; Yuka Takahashi; Shintaro Ogawa; Yasuhito Tanaka; Yasuhiro Asahina; Namiki Izumi
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

3.  Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice.

Authors:  Volodymyr P Tryndyak; Tao Han; James C Fuscoe; Sharon A Ross; Frederick A Beland; Igor P Pogribny
Journal:  BMC Genomics       Date:  2016-04-22       Impact factor: 3.969

4.  Association of sorting and assembly machinery component 50 homolog gene polymorphisms with nonalcoholic fatty liver disease susceptibility.

Authors:  Ming Qiao; Jian-Hua Yang; Yi Zhu; Jun-Ping Hu
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

Review 5.  Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes.

Authors:  Arianna Ricciardello; Pasquale Tomaiuolo; Antonio M Persico
Journal:  Am J Med Genet A       Date:  2021-05-05       Impact factor: 2.802

6.  Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease.

Authors:  Shamsul Mohd Zain; Zahurin Mohamed; Munir Pirmohamed; Hwa Li Tan; Mohammed Abdullah Alshawsh; Sanjiv Mahadeva; Wah-Kheong Chan; Nik Raihan Nik Mustapha; Rosmawati Mohamed
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

7.  Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.

Authors:  Kikuko Hotta; Aya Kitamoto; Takuya Kitamoto; Yuji Ogawa; Yasushi Honda; Takaomi Kessoku; Masato Yoneda; Kento Imajo; Wataru Tomeno; Satoru Saito; Atsushi Nakajima
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.